50 results on '"American College of Rheumatology -- Standards"'
Search Results
2. Systemic lupus erythematosus: the devastatingly deceptive disease
3. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase 1
4. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
5. Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis
6. Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
7. Disease chronicity and activity predict subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus
8. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis
9. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
10. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study
11. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
12. Golimumab, a human antibody to tumour necrosis factor (alpha) given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
13. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor (alpha) therapy in rheumatoid arthritis
14. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles
15. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
16. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity
17. Measuring quality of care for rheumatic diseases using an electronic medical record
18. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis
19. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
20. Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
21. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
22. Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
23. Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care
24. How and when to use DMARDs
25. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). (Consensus Statement)
26. Systemic lupus erythematosus presenting as a subacute delirium in an 82-year-old woman
27. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis
28. Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE(R) Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing
29. A welcome address for the new criteria
30. What does the clinician need to improve patient care in systemic sclerosis?
31. Risk score validated for major NSAID adverse events
32. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
33. NSAIDs: Drug of Choice for Severe Osteoarthritis
34. Guidelines update
35. Updated ACR guidelines for management of RA: new therapies target inflammation; early treatment recommended. (Clinical Update)
36. The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changer
37. Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care
38. Small joint ankylosis in rheumatoid arthritis: a vanishing phenomenon or a pathogenetic clue, or both?
39. Stretch and stay loose: keep your body limber and your joints happy
40. Guidelines aim to prevent Steroid-Induced osteoporosis. (Drug Update)
41. Gout Management Is Focus of New Guidelines; Key practices for doctors, patients outlined by American College of Rheumatology
42. New Guidelines Issued for Severe Lupus; More can be done to prevent permanent kidney damage, says American College of Rheumatology
43. The use and misuse of classification and diagnostic criteria for complex diseases
44. New guidelines help providers manage rheumatoid arthritis
45. Musculoskeletal problems: a rational approach
46. Reports Summarize Arthritis Study Results from University College (How Much Is Fatigue Explained by Standard Clinical Characteristics of Disease Activity in Patients With Inflammatory Arthritis? A Longitudinal Study)
47. Fibromyalgia diagnosis, therapy vary by provider
48. Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis
49. RA guide urges use of DMARDs within 3 months: 'The bar has been raised'. (Clinical Rounds)
50. Treating wear and tear of joints
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.